NCT06385093View on ClinicalTrials.gov

A Study on the Prevention and Treatment of GIOP With Eldecalcitol

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Rheumatoid ArthritisOsteoporosisOsteopenia
Interventions
DRUG

Eldecalcitol capsules

Oral eldecalcitol 0.75μg daily

DRUG

Alfacalcidol tablets

Oral Alfacalcidol 0.5μg daily

DRUG

Calcium carbonate tablets

1.5g Calcium carbonate daily

Trial Locations (7)

100730

Peking Union Medical College Hospital, Beijing

Unknown

Aerospace Central Hospital, Beijing

Beijing Luhe hospital, Capital Medical University, Beijing

Beijing Shijingshan Hospital, Beijing

Beijing Shijitan Hospital, Beijing

Beijing Shunyi hospital, Beijing

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
collaborator

Beijing Life oasis public service center

UNKNOWN

lead

Chinese SLE Treatment And Research Group

OTHER

NCT06385093 - A Study on the Prevention and Treatment of GIOP With Eldecalcitol | Biotech Hunter | Biotech Hunter